Jigar Mistry of Buoyant Capital favors healthcare, materials, chemicals, and banking sectors, preferring large-cap private banks over PSU banks. He remains positive on both generic and CDMO pharma segments, dismissing tariff concerns. Mistry believes valuations are elevated, especially for narrative-driven stocks lacking earnings, advocating for a focus on fundamentals over market flows.
F&O Talk| Indian markets in mature uptrend, Nifty now eyeing 26k: Rahul Ghose
Markets snapped their five-week-long consolidation trend, driven by improving global cues, easing geopolitical concerns, and a renewed uptick in foreign institutional investor (FII) buying during
June 29, 2025